Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
Clinical trial NCT01340651 · COMPLETED
Trial details
- NCT number
- NCT01340651
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.